Fiztasovimab Antibody
Fiztasovimab (NPC-21; EV2038) is a fully human monoclonal antibody that neutralizes human cytomegalovirus (hCMV) by targeting glycoprotein B's antigenic domain 1. This mechanism blocks viral cell-to-cell spread, making it a valuable tool for in vitro virology studies and research into hCMV pathogenesis and therapeutic strategies.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog